欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

蛋白激酶CEpsilon:前列腺癌中的新型致癌物质

PKC Epsilon: A Novel Oncogenic Player in Prostate Cancer

作者:Garg, R. 加工时间:2015-08-23 信息来源:科技报告(AD) 索取原文[15 页]
关键词:前列腺癌;细胞(生物学);酯类;基因
摘 要:Protein kinase C epsilon (PKCe), a member of the PKC family of phorbol ester/diacylglycerol receptors, is up-regulated in many human cancers, including prostate cancer. We recently demonstrated that PKCe is an essential mediator of NF-kB activation in prostate cancer (Garg et al., JBC, 287, 37570 37582, 2012). In this research, we wish to determine if PKCe regulates TNFa- signaling to mediate its effect on NF-kB activation. Using a specific PKCe antagonist, we demonstrated that PKCe plays essential role in the TNFa-induced phosphorylation of TNF receptor in prostate cancer cells. We have previously identified that PKCe regulates NF-kB responsive genes in prostate cancer cells, including cyclooxygenase-2 (COX-2) (JBC, 2012). COX-2 has been reported to be up-regulated in metastatic prostate cancer. As PKCe plays an important role in prostate cancer cell survival and cooperates with other oncogenic insults, herein we aim to determine if PKCe regulates COX-2 activation during prostate tumorigenesis. We observe that PKCe RNAi depletion diminishes constitutive and stimulated COX-2 mRNA expression and PGE2 levels in prostate cancer cells. Conversely, PKCe overexpression by adenoviral means potentiates COX-2 expression in LNCaP cells. Thus, our study characterizes a novel molecular link between PKCe and NF-kB/COX-2 and its implication in survival pathways in prostate cancer.
© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服